Literature DB >> 17653204

Group-II metabotropic glutamate receptor ligands as adjunctive drugs in the treatment of depression: a new strategy to shorten the latency of antidepressant medication?

F Matrisciano, I Panaccione, M Zusso, P Giusti, R Tatarelli, L Iacovelli, A A Mathé, S H M Gruber, F Nicoletti, P Girardi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17653204     DOI: 10.1038/sj.mp.4002005

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


× No keyword cloud information.
  13 in total

1.  Radiosynthesis of PET radiotracer as a prodrug for imaging group II metabotropic glutamate receptors in vivo.

Authors:  Ji-Quan Wang; Zhaoda Zhang; Darshini Kuruppu; Anna-Liisa Brownell
Journal:  Bioorg Med Chem Lett       Date:  2012-01-21       Impact factor: 2.823

2.  Development of a novel, CNS-penetrant, metabotropic glutamate receptor 3 (mGlu3) NAM probe (ML289) derived from a closely related mGlu5 PAM.

Authors:  Douglas J Sheffler; Cody J Wenthur; Joshua A Bruner; Sheridan J S Carrington; Paige N Vinson; Kiran K Gogi; Anna L Blobaum; Ryan D Morrison; Mitchell Vamos; Nicholas D P Cosford; Shaun R Stauffer; J Scott Daniels; Colleen M Niswender; P Jeffrey Conn; Craig W Lindsley
Journal:  Bioorg Med Chem Lett       Date:  2012-04-30       Impact factor: 2.823

3.  Synthesis and SAR of substituted pyrazolo[1,5-a]quinazolines as dual mGlu(2)/mGlu(3) NAMs.

Authors:  Cody J Wenthur; Ryan D Morrison; J Scott Daniels; P Jeffrey Conn; Craig W Lindsley
Journal:  Bioorg Med Chem Lett       Date:  2014-04-20       Impact factor: 2.823

4.  L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors.

Authors:  Carla Nasca; Dionysios Xenos; Ylenia Barone; Alessandra Caruso; Sergio Scaccianoce; Francesco Matrisciano; Giuseppe Battaglia; Aleksander A Mathé; Anna Pittaluga; Luana Lionetto; Maurizio Simmaco; Ferdinando Nicoletti
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

5.  Extending the Specificity of DRL 72-s Behavior for Screening Antidepressant-Like Effects of Glutamatergic Clinically Validated Anxiolytic or Antidepressant Drugs in Rats.

Authors:  Gerard J Marek; Allyson A Salek
Journal:  J Pharmacol Exp Ther       Date:  2020-04-07       Impact factor: 4.030

Review 6.  Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs.

Authors:  Mark J Millan
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

7.  Anxiety-like behavior of prenatally stressed rats is associated with a selective reduction of glutamate release in the ventral hippocampus.

Authors:  Jordan Marrocco; Jérôme Mairesse; Richard Teke Ngomba; Viviana Silletti; Gilles Van Camp; Hammou Bouwalerh; Maria Summa; Anna Pittaluga; Ferdinando Nicoletti; Stefania Maccari; Sara Morley-Fletcher
Journal:  J Neurosci       Date:  2012-11-28       Impact factor: 6.167

Review 8.  Metabotropic glutamate receptors: from the workbench to the bedside.

Authors:  F Nicoletti; J Bockaert; G L Collingridge; P J Conn; F Ferraguti; D D Schoepp; J T Wroblewski; J P Pin
Journal:  Neuropharmacology       Date:  2010-10-29       Impact factor: 5.250

9.  Effects of transmitters and amyloid-beta peptide on calcium signals in rat cortical astrocytes: Fura-2AM measurements and stochastic model simulations.

Authors:  Eeva Toivari; Tiina Manninen; Amit K Nahata; Tuula O Jalonen; Marja-Leena Linne
Journal:  PLoS One       Date:  2011-03-29       Impact factor: 3.240

10.  Chronic agomelatine treatment corrects behavioral, cellular, and biochemical abnormalities induced by prenatal stress in rats.

Authors:  Sara Morley-Fletcher; Jerome Mairesse; Amelie Soumier; Mounira Banasr; Francesca Fagioli; Cecilia Gabriel; Elisabeth Mocaer; Annie Daszuta; Bruce McEwen; Ferdinando Nicoletti; Stefania Maccari
Journal:  Psychopharmacology (Berl)       Date:  2011-04-19       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.